PELLEGRINO, Michele
 Distribuzione geografica
Continente #
NA - Nord America 2.139
EU - Europa 1.453
AS - Asia 656
AF - Africa 47
SA - Sud America 10
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.316
Nazione #
US - Stati Uniti d'America 2.079
UA - Ucraina 425
DE - Germania 276
AT - Austria 266
CN - Cina 224
SG - Singapore 211
IT - Italia 188
SE - Svezia 120
HK - Hong Kong 87
FR - Francia 61
CA - Canada 56
TR - Turchia 54
IN - India 49
SN - Senegal 44
FI - Finlandia 31
GB - Regno Unito 21
BE - Belgio 18
CZ - Repubblica Ceca 16
KR - Corea 13
IR - Iran 7
NL - Olanda 7
AU - Australia 6
CH - Svizzera 4
EU - Europa 4
MX - Messico 4
BR - Brasile 3
EC - Ecuador 3
ID - Indonesia 3
PT - Portogallo 3
RU - Federazione Russa 3
BG - Bulgaria 2
MK - Macedonia 2
PE - Perù 2
PK - Pakistan 2
PL - Polonia 2
RO - Romania 2
RS - Serbia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
KZ - Kazakistan 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 4.316
Città #
Chandler 355
Jacksonville 247
Boardman 187
Vienna 176
Singapore 167
San Mateo 166
Dearborn 133
New York 105
Ashburn 75
Shanghai 64
Lawrence 62
Roxbury 61
Izmir 48
Rende 45
Dakar 44
Des Moines 44
Ottawa 42
Ann Arbor 35
Brooklyn 35
Beijing 34
Grafing 32
Bremen 31
Helsinki 29
Hong Kong 27
Wilmington 24
Redwood City 20
Inglewood 19
Brussels 18
Seattle 17
Cambridge 16
Florence 16
Ogden 16
Falls Church 15
Pune 15
Seoul 13
Brno 12
Toronto 12
Wuhan 9
Guangzhou 8
San Francisco 8
Cosenza 7
Munich 7
Wuxi 7
Chennai 6
Los Angeles 6
Houston 5
Augusta 4
Bari 4
Catanzaro 4
Feroleto della Chiesa 4
Hanover 4
Jiaxing 4
Milan 4
Nanjing 4
Olomouc 4
Quanzhou 4
Rome 4
Sittard 4
Amantea 3
Ardabil 3
Belvedere Marittimo 3
Berlin 3
Canberra 3
Jinhua 3
Kilburn 3
London 3
Melbourne 3
Monmouth Junction 3
New Delhi 3
Quito 3
Shenyang 3
Shenzhen 3
Bandung 2
Belgrade 2
Birmingham 2
Bornova 2
Cappelle sul Tavo 2
Castrolibero 2
Castrovillari 2
Edinburgh 2
Faisalabad 2
Geneve 2
Groningen 2
Hangzhou 2
Hefei 2
Jaipur 2
Kolkata 2
Kuy-e Ekhtesasi-ye Gomrok 2
Lappeenranta 2
Lima 2
Lodi 2
Mammola 2
Mascalucia 2
Mumbai 2
Nanchang 2
Naples 2
Norwalk 2
Palermo 2
Palmi 2
Reggio Calabria 2
Totale 2.666
Nome #
3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression 137
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression 117
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells 114
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression. 112
Bortezomib-loaded mesoporous silica nanoparticles selectively alter metabolism and induce death in multiple myeloma cells 112
Transferrin-conjugated pluronic niosomes as a new drug delivery sistem for anticancer therapy 108
Estrogenic GPER signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (CAFs) 101
Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy 100
Anticancer activity of a hydrogel containing folic acid towards MCF-7 and MDA-MB-231 cells 100
Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer 98
E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor 98
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ER. 2nd Joint Meeting of Pathology and Laboratory Diagnostics, 2014 September 17-20, Palermo, Italy. Am J Pathol ,184(Suppl):S34 Abstract MTP1, 2014. Oral communication 95
Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination 91
Cachrys spp. from Southern Italy: Phytochemical Characterization and JAK/STAT Signaling Pathway Inhibition 84
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ERα 83
Dealing with skin and blood-brain barriers: The unconventional challenges of mesoporous silica nanoparticles 83
Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells 80
Evidence that low doses of taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells 78
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 78
GPER mediates activation of HIF1α/VEGF signaling by estrogens 75
Evidences that leptin upregulates E-cadherin expression in breast cancer and promotes tumor cell growth and progression 75
Evidences that Estrogen Receptor alpha interferes with adiponectin effects on breast cancer cell growth 72
Chitosan membranes filled with cyclosporine a as possible devices for local administration of drugs in the treatment of breast cancer 72
Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism 70
Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor 70
Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells 68
GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer 67
FoxO3a mediates the inhibitory effects of the antiepileptic drug Lamotrigine on breast cancer growth 67
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies. 67
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 66
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts 66
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 65
In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer. 61
Evidences that leptin upregulates E-cadherin expression in breast cancer: effects on tumor growth and progression 60
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics 60
Tamoxifen and epidermal growth factor induce the aggregation of MCF7 breast cancer cells up-regulating E-cadherin expression 56
Fas ligand in TM4 cells is up-regulated by estradiol through Estrogen Receptor alpha interaction with Sp-1 53
Molecular mechanism through which leptin upregulates e-cadherin expression and influences breast cancer cell growth and progression 52
The antiepileptic drug Lamotrigine, through FoxO3a, inhibits breast cancer growth and development both in vitro and in vivo. Pellegrino M, Rizza P, Giordano F, Spina E, Ceraldi R, Andò S, Morelli C, Sisci D. 51
PI3-kinase/Akt pathway is involved in the short non genomic autocrine loop between 17-β estradiol and aromatase activity in MCF-7 cells. 50
The modulatory role of IRS-1 on cell adhesion in human breast cancer cells 49
Fas ligand expression in TM4 sertoli cells is enhanced by estradiol "in situ" production 48
Evidences that leptin upregulates E-cadherin expression in breast cancer: effects on tumor growth and progression 48
PPARγ ligand rosiglitazone counteracts the stimulatory effectsof leptin on breast cancer growth 47
PI3-kinase/Akt pathway is involved in the short non genomic autocrine loop between 17-beta estradiol and aromatase activity in MCF-7 cells 46
Foxo3a inhibits tamoxifen-resistant breast cancer progression by inducing integrin α5 expression 46
PPAR-gamma ligand rosiglitazone counteracts the stimulatory effect of leptin on breast cancer growth 45
Production of Plant-Derived Oleuropein Aglycone by a Combined Membrane Process and Evaluation of Its Breast Anticancer Properties 44
Biocompatible targeting hydrogels for breast cancer treatment 43
PPARγ ligands as antagonists of leptin signaling in breast cancer: in vivo and in vitro effects 43
Peroxisome proliferator-activated receptor (PPAR)gamma is expressed by human spermatozoa: its potential role on the sperm physiology 42
Inhibitory effect of adiponectin on breast cancer cell growth: evidences of the crucial role of ER{alpha} expression 41
Taxol activates p21 waf promoter, via p53, in MCF-7 breast cance cells 41
PPARgamma ligands as antagonists of leptin signaling in breast cancer: in vivo and in vitro effects 40
First evidences that Resveratrol through p53/Sin3/HDAC1 complex phosphorylation inhibits ESR1 gene expression via p38MAPK signalling.expression via p38MAPK/CK2 signalling in human breast cancer cells 40
PPAR gama ligand rosiglitazone counteracts the stimmulatory effect of leptin on breast cancer growth 39
Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism. (corresponding author) 38
Resveratrol through p53/Sin3/HDAC1 complex phosphorylation inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signalling in human breast cancer cells 38
Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages 38
The pMAPK/pAMPK ratio modulates the effect of adiponectin on breast cancer cell growth 37
Molecular mechanism trough which leptin upregulates E-cadherin expression in breast cancer. In vitro and in vivo effects on tumor cell growth and progression. 35
Role of ER-α in the modulatory effect of adiponectin on breast cancer cell growth 31
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway 29
N-Heterocyclic Carbene-Gold(I) Complexes Targeting Actin Polymerization 29
Triclosan: A Small Molecule with Controversial Roles 23
Application of Natural Edible Coating to Enhance the Shelf Life of Red Fruits and their bioactive content 22
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 20
N-Heterocyclic Carbene (NHC) Silver Complexes as Versatile Chemotherapeutic Agents Targeting Human Topoisomerases and Actin 20
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic. 20
Identification of Pinosylvin in Pinus nigra subsp. laricio: A Naturally Occurring Stilbenoid Suppressing LPS-Induced Expression of Pro-Inflammatory Cytokines and Mediators and Inhibiting the JAK/STAT Signaling Pathway 20
Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs 16
Enhancing the Anticancer and Anti-Inflammatory Properties of Curcumin in Combination with Quercetin, for the Prevention and Treatment of Prostate Cancer 14
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 14
Food System Transformation and Gut Microbiota Transition: Evidence on Advancing Obesity, Cardiovascular Diseases, and Cancers-A Narrative Review 12
Synthesis of novel N-Heterocyclic carbene-Ruthenium (II) complexes, “precious” tools with antibacterial, anticancer and antioxidant properties. 12
HIV-1 Structural Proteins or Cell-Signaling Factors? That Is the Question! 10
From HDAC to Voltage-Gated Ion Channels: What's Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer 10
The Ongoing Impact of COVID-19 on Pediatric Obesity 9
Silver and Gold Complexes with NHC-Ligands Derived from Caffeine: Catalytic and Pharmacological Activity 8
New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs 6
Modulation of energetic and lipid pathways by curcumin as a potential chemopreventive strategy in human prostate cancer cells 5
Totale 4.430
Categoria #
all - tutte 31.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020394 0 0 0 0 37 131 39 60 14 19 60 34
2020/2021495 66 3 52 62 7 65 17 62 36 64 13 48
2021/2022863 15 115 10 44 96 53 11 178 13 13 119 196
2022/20231.077 139 121 51 126 131 81 27 89 145 32 97 38
2023/2024738 81 23 53 22 42 182 26 43 60 21 32 153
2024/2025509 111 188 52 129 29 0 0 0 0 0 0 0
Totale 4.430